Compass Pathways released six-month data from its second Phase 3 trial of COMP360 psilocybin for treatment-resistant depression. Thirty-nine percen...
A fly learns to fear an odor. To lock in what it learned, its brain fakes a hunger signal. The fasting is fictional. The memory is real.